Fiche centre
Tianjin People's Hospital
Tianjin — China
Essais liés3clinical trials
VilleTianjinlocalisation
PaysChinalocalisation
SourcelocaleCSV/MySQL
Informations
centreSynchronisé depuis ClinicalTrials.gov — NCT07835152
Essais cliniques associés
3| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| IBI301 | SEP | Phase 1 | NCT02945215 | A Study to Assess the Pharmacokinetics and Safety of Recombinant Human Murine Chimeric Anti CD20 Monoclonal Antibody Injection (IBI301) Compared to Rituximab Injection in CD20 Positive B Cell Lymphoma Patients | COMPLETED |
| BR005-036C | Migraine | Phase 3 | NCT07835152 | Long-term Safety of BR005-036C Tablets in the Acute Treatment of Migraine in Adults | NOT_YET_RECRUITING |
| BR005-036C | Migraine | Phase 2/3 | NCT07792681 | Efficacy and Safety of BR005-036C Tablets for the Acute Treatment of Migraine in Adults | RECRUITING |